trending Market Intelligence /marketintelligence/en/news-insights/trending/wdomxjsdgv8nvdkskbpk4a2 content esgSubNav
In This List

Catalent board member resigns; 3 board members added

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Catalent board member resigns; 3 board members added

New Jersey-based Catalent Inc. said James Quella retired as a board member after nine years of service.

Concurrently, the pharmaceuticals company added Rosemary Crane, John Greisch and Christa Kreuzburg to its board

Crane serves as a board member for Edge Therapeutics Inc., Teva Pharmaceutical Industries Ltd. and Zealand Pharma A/S. She retired in 2014 from MELA Sciences Inc., where she served as president and CEO.

Greisch is set to retire later in 2018 as the president and CEO of Hill-Rom Holdings Inc.

Kreuzburg has been a consultant in the healthcare sector after retiring from Bayer AG in 2009. She is a board member of Tecan Trading AG.